TRB Chemedica International Overview
- Founded
-
1980

- Status
-
Private
- Employees
-
201

- Latest Deal Type
-
Corporate
- Financing Rounds
-
1
TRB Chemedica International General Information
Description
Manufacturer and supplier of chemical and pharmaceutical products. The company engages in research, development and marketing of patented pharmaceutical products and medical devices in the areas of rheumatology, ophthalmology and neurology.
Contact Information
Website
www.trbchemedica.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Other Devices and Supplies
Primary Office
- 12, rue Michel Servet
- P.O. Box 352
- 1211 Geneva
- Switzerland
+41 022 000 00 00
TRB Chemedica International Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
TRB Chemedica International Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Manufacturer and supplier of chemical and pharmaceutical products. The company engages in research, development and mark
Pharmaceuticals
Geneva, Switzerland
201
As of 2015
000000000000
TRB Chemedica International Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
00000000 000000000 | Formerly PE-Backed | Chaska, MN | 000 | 00000 | 000000000 00 | 00000 |
TRB Chemedica International Patents
TRB Chemedica International Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2020410540-A1 | Use of hyaluronic acid derivatives in the regeneration of bone and cartilage tissues | Pending | 20-Dec-2019 | 0000000000 | |
CA-3162397-A1 | Use of hyaluronic acid derivatives in the regeneration of bone and cartilage tissues | Pending | 20-Dec-2019 | 0000000000 | |
EP-4076428-A1 | Use of hyaluronic acid derivatives in the regeneration of bone and cartilage tissues | Pending | 20-Dec-2019 | 0000000000 | |
US-20230018851-A1 | Use of hyaluronic acid derivatives in the regeneration of bone and cartilage tissues | Pending | 20-Dec-2019 | 0000000000 | |
CA-2864050-A1 | Method for repair of ligament or tendon | Inactive | 22-Mar-2012 | A61L27/24 |
TRB Chemedica International Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Alessandro Di Napoli | Vice President, Scientific and Marketing |
TRB Chemedica International Signals
TRB Chemedica International Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|